Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Disinfectant Efficacy: Understanding the Expectations and How to Design Effective Studies That Include Leveraging Multi-Site Data to Drive an Efficient Program

Derek Willison-Parry, Stephen Yang, Ren-Yo Forng, Tim Cirbo, Aileen Mcmeel, Brian Kiler and Christopher Phillion
PDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 249-263; DOI: https://doi.org/10.5731/pdajpst.2018.009662
Derek Willison-Parry
1BioPhorum, London, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: derek@biophorum.com
Stephen Yang
2Merck & Co., Inc, Kenilworth, NJ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-Yo Forng
3Amgen, Thousand Oaks, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Cirbo
4Eli Lilly, Indianapolis, IN;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aileen Mcmeel
5Pfizer, New York, NY;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Kiler
6Roche, Basel, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Phillion
7Takeda, Cambridge, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    U.S. Food and Drug Administration, 21 CFR part 211–Current Good Manufacturing Practice for Finished Pharmaceuticals, Section 211.67 Equipment Cleaning and Maintenance. U.S. Department of Health and Human Services. Government Publishing Office: Washington D.C., 2016.
  2. 2.↵
    U.S. Food and Drug Administration, 21 CFR part 211–Current Good Manufacturing Practice for Finished Pharmaceuticals, Section 211.182 Equipment Cleaning and Use Log. U.S. Department of Health and Human Services. Government Publishing Office: Washington D.C., 2016.
  3. 3.↵
    U.S. Pharmacopeial Convention, General Chapter <1072> Disinfectants and Antiseptics. https://www/uspnf.com (accessed Aug 28, 2018).
  4. 4.↵
    U.S. Food and Drug Administration, Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice. Center for Biologics Evaluation and Research. U.S. Department of Health and Human Services: Rockville, MD, 2004.
  5. 5.↵
    ASTM International, ASTM E2614-15 Standard Guide for Evaluation of Cleanroom Disinfectants. ASTM: West Conshohocken, PA, 2018.
  6. 6.↵
    ASTM International, ASTM E2197-17 Standard Quantitative Disk Carrier Test Method for Determining Bactericidal, Virucidal, Fungicidal, Mycobactericidal, and Sporicidal Activities of Chemicals. ASTM: West Conshohocken, PA, 2018.
  7. 7.↵
    International Organization for Standardization, ISO 14698: Cleanrooms and Associated Controlled Environments. ISO: Geneva, 2003.
  8. 8.↵
    Parenteral Drug Association Inc. Technical Report No. 70: Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities; Bethesda, MD, 2015.
  9. 9.↵
    Parenteral Drug Association Inc. Technical Report No. 29—Revised 2012: Points to Consider for Cleaning Validation; Bethesda, MD, 2012.
  10. 10.↵
    British Standard, EN 13697: Quantitative Surface Test for the Evaluation of Bactericidal or Fungicidal Activity, London, UK, 2015.
  11. 11.↵
    ASTM International, ASTM E1153-14 Standard Test Method for Efficacy of Sanitizers Recommended for Inanimate, Hard, Nonporous Non-Food Contact Surfaces. ASTM: West Conshohocken, PA, 2018.
  12. 12.↵
    Hard Surface Carrier Test Methods. In Official Methods of Analysis; AOAC International, 2016; Chapter 6.2.
  13. 13.↵
    U.S. Pharmacopeial Convention, General Chapter <1231> Water for Pharmaceutical Purposes. https://www/uspnf.com (accessed Aug 28, 2018).
  14. 14.↵
    1. Fraise A. P.,
    2. Lambert P. A.,
    3. Maillard J. -Y.
    Russell, Hugo & Ayliffe's Principles and Practice of Disinfection, Preservation and Sterilization; Fraise A. P., Lambert P. A., Maillard J. -Y., Eds.; Blackwell Publishing Ltd, Oxford, UK, 2004.
  15. 15.↵
    U.S. Pharmacopeial Convention, General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. https://www/uspnf.com (accessed Aug 28, 2018).
  16. 16.↵
    1. Clayton J.
    Demystifying Disinfectant Contact Time. Healthcare Purchasing News [Online], Sept 21, 2017. http://www.hpnonline.com/demystifying-disinfectant-contact-time (accessed Aug 28, 2018).
  17. 17.↵
    European Commission, Eudralex–The Rules Governing Medicinal Products in the European Union, Volume 4: Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation. European Commission: Brussels, 2018.
  18. 18.↵
    U.S. Pharmacopeial Convention, General Chapter <1227> Validation of Microbial Recovery from Pharmacopeial Articles. https://www/uspnf.com (accessed Aug 28, 2018).
  19. 19.
    1. McDonnell G. E.
    Antisepsis, Disinfection, and Sterilization: Types, Action, and Resistance; ASM Press: Washington DC, 2007.
  20. 20.
    1. Rutala W. A,
    2. Weber D. J.
    ; and the Healthcare Infection Control Practices Advisory Committee. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Center for Disease Control and Prevention Web Site http://www.cdc.gov/infectioncontrol/pdf/guidelines/disinfection-guidelines-H.pdf (accessed Aug 28, 2018).
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 74 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 2
March/April 2020
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Disinfectant Efficacy: Understanding the Expectations and How to Design Effective Studies That Include Leveraging Multi-Site Data to Drive an Efficient Program
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Disinfectant Efficacy: Understanding the Expectations and How to Design Effective Studies That Include Leveraging Multi-Site Data to Drive an Efficient Program
Derek Willison-Parry, Stephen Yang, Ren-Yo Forng, Tim Cirbo, Aileen Mcmeel, Brian Kiler, Christopher Phillion
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 249-263; DOI: 10.5731/pdajpst.2018.009662

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Disinfectant Efficacy: Understanding the Expectations and How to Design Effective Studies That Include Leveraging Multi-Site Data to Drive an Efficient Program
Derek Willison-Parry, Stephen Yang, Ren-Yo Forng, Tim Cirbo, Aileen Mcmeel, Brian Kiler, Christopher Phillion
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 249-263; DOI: 10.5731/pdajpst.2018.009662
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Categories of Disinfectants and How They Differ
    • 3. Regulatory expectations with Regard to Disinfectant Efficacy Testing
    • 4. The Value of Environmental Monitoring Trending to Disinfectant Efficacy Testing
    • 5. Challenge Organism Selection for Disinfectant Efficacy Testing
    • 6. Challenge Surface Selection
    • 7. Leveraging Disinfectant Efficacy Data for Multiple Facilities
    • 8. Critical Parameters and the Holistic Management of a Disinfectant Efficacy Study Validation Program
    • 9. How to Bring a New Material into the Program
    • 10. Conclusion
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
  • Expanding the Use of Moist Heat for Terminal Sterilization
Show more Commentary

Similar Articles

Keywords

  • BioPhorum
  • Disinfectant efficacy
  • Cleaning
  • Cleaning requirements
  • Control awareness

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire